Author:
SCHWEIZER EDWARD,WEISE CHARLES,CLARY CATHRYN,FOX IRA,RICKELS KARL
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Psychiatry and Mental health
Cited by
74 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder;Expert Opinion on Pharmacotherapy;2023-08-07
2. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Venlafaxine, Desvenlafaxine, Duloxetine, Milnacipran, Levomilnacipran;NeuroPsychopharmacotherapy;2022
3. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) Venlafaxine, Desvenlafaxine, Duloxetine, Milnacipran, Levomilnacipran;NeuroPsychopharmacotherapy;2022
4. Pharmacoepidemiological and pharmacoeconomic study of the structure of prescribing antidepressants in anxiety-depressive disorders;Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery);2021-06-11
5. Serotonin and Norepinephrine Reuptake Inhibitors;Antidepressants;2018